Category Finance

WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines

The World Health Organization Executive Board today approved a modified resolution on neglected tropical diseases – after removing a reference to a working group on R&D for neglected diseases as “irrelevant”. The Board also discussed and took note of a report on poor quality medical products in the supply chain, and agreed to set another meeting on the issue before the May World Health Assembly, as well as set up a separate group on behaviours that lead to this problem.

Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor

World Health Organization members on Friday held a tense discussion over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development for neglected diseases predominantly afflicting poor populations. The discussion may continue today, with the linkage of an agenda item on neglected tropical diseases and the report of an expert working group offering numerous ideas for addressing the problem.

Official Offers Reflections On WHO Reform, Private Sector Role

In 2011, Margaret Chan, director general of the World Health Organization, launched a major reform of the United Nations organisation. This week, a presentation and discussions around the WHO reform by Gaudenz Silberschmidt, senior adviser in the WHO Office of the Director-General, highlighted the reason for this reform, its organisation and the possible impact the reform could have on the relationship between the pharmaceutical industry and the WHO.

EPO Staff To Get Disputed €28M Bonus, Despite Protest

The European Patent Office Administrative Council in December agreed to award a controversial bonus of tens of millions of euros to EPO staff at the end of 2012, with 24 positive votes and 8 negative votes. Several stakeholders had protested the proposal and encouraged contracting states in the Administrative Council to vote against the measure.

IP-Watch Looks At The Year Ahead In International IP Policy

What will 2013 bring for international intellectual property and innovation policy?

In the coming Intellectual Property Watch series for subscribers, our expert writers take a look at the top global policy issues and events in copyright, public health, legal battles, food security/biotech/biodiversity, trade, development, internet governance and more.

Collaborative Capacity Building In Intellectual Property — Leveraging On African Diaspora Exchange

Depending on where one locates its advent, contemporary globalization is now more than half a century old. It might be asked whether globalization has been beneficial to Africa. One quick and easy way of addressing this often asked question is to cursorily look at the regional dynamics of over half century of globalization. And this leads to an urgent call for "homeland-Diaspora" intellectual property training, says Prof. Chidi Oguamanam.

WHO Members Agree On “Strategic Work Plan” On Health R&D – But No Convention

After three days and two nights of tough negotiations to address the global gap in research and development for neglected diseases at the World Health Organization, member states agreed to endorse a strategic work plan that includes proposals on the coordination, financing, and monitoring of R&D expenditures separately, but not to advance the idea of an overarching framework. The recommendation for a global R&D convention proved divisive to the very end of the negotiations.

WHO Negotiations To Address Medical R&D Global Gaps Head Deep Into Night

Negotiations on the follow-up of the report of the expert group on research and development for neglected diseases tonight were continuing in a late-night session at the World Health Organization. At press time, member states were discussing options to address the research coordination, financing, and monitoring of medical R&D expenditures for the health needs of developing countries.

International Instrument On Medical R&D Still On Negotiating Table At WHO

World Health Organization member states gathering this week at the WHO headquarters in a meeting to address global gaps in the drug development system said that there is still much work to be done before consensus can be reached on a resolution. For now, the latest draft resolution keeps a wide range of monitoring, coordinating, and financing options on the table, not yet setting a clear direction.

UNITAID: Alternative Funding Mechanism For AIDS Drugs Saving Lives

UNITAID, an alternative funding mechanism for pharmaceuticals to the poor, said today that its work has helped develop new ways to treat children infected with HIV where there was previously little commercial incentive. The statement alongside the World AIDS Day announcement that the number of newly infected children continues to decline. UNITAID called for the international community to help children already living with the disease.